CN115209895A - 含l-麦角硫因的组合物 - Google Patents

含l-麦角硫因的组合物 Download PDF

Info

Publication number
CN115209895A
CN115209895A CN202180018596.6A CN202180018596A CN115209895A CN 115209895 A CN115209895 A CN 115209895A CN 202180018596 A CN202180018596 A CN 202180018596A CN 115209895 A CN115209895 A CN 115209895A
Authority
CN
China
Prior art keywords
egt
dth
composition
mass
ergothioneine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180018596.6A
Other languages
English (en)
Chinese (zh)
Inventor
仲谷豪
仲岛菜菜实
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nagase and Co Ltd
Original Assignee
Nagase and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nagase and Co Ltd filed Critical Nagase and Co Ltd
Publication of CN115209895A publication Critical patent/CN115209895A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
CN202180018596.6A 2020-03-04 2021-03-04 含l-麦角硫因的组合物 Pending CN115209895A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020-036577 2020-03-04
JP2020036577A JP6864131B1 (ja) 2020-03-04 2020-03-04 Ｌ−エルゴチオネイン含有組成物
PCT/JP2021/008388 WO2021177397A1 (ja) 2020-03-04 2021-03-04 Ｌ－エルゴチオネイン含有組成物

Publications (1)

Publication Number Publication Date
CN115209895A true CN115209895A (zh) 2022-10-18

Family

ID=75638746

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180018596.6A Pending CN115209895A (zh) 2020-03-04 2021-03-04 含l-麦角硫因的组合物

Country Status (8)

Country Link
US (1) US12357614B2 (https=)
EP (1) EP4115881A4 (https=)
JP (3) JP6864131B1 (https=)
KR (1) KR20220149718A (https=)
CN (1) CN115209895A (https=)
CA (1) CA3170408A1 (https=)
TW (1) TW202146013A (https=)
WO (1) WO2021177397A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118215476A (zh) * 2021-11-08 2024-06-18 三菱瓦斯化学株式会社 用于抑制或预防内耳性耳聋的含有麦角硫因的组合物
KR20240127428A (ko) * 2021-12-23 2024-08-22 산토리 홀딩스 가부시키가이샤 경구 조성물 및 소프트 캡슐제
CN121311472A (zh) * 2023-06-15 2026-01-09 长濑产业株式会社 化合物或其盐及其制造方法、组合物、过氧化氢清除剂以及细胞毒性抑制剂
WO2025142813A1 (ja) * 2023-12-27 2025-07-03 サントリーホールディングス株式会社 経口組成物

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707086A1 (fr) * 1993-06-28 1995-01-06 Bioxytech Procédé de préparation de l'ergothionéine.
CN101209229A (zh) * 2006-12-29 2008-07-02 Lvmh研究公司 L-2-硫代组氨酸或其衍生物之一作为脱色剂在化妆品中的应用
JP2009126863A (ja) * 2007-11-27 2009-06-11 Koei Kogyo Kk キノコから抽出したエルゴチオネインを高含有する組成物
CN102686568A (zh) * 2009-10-06 2012-09-19 四面体公司 麦角硫因及类似物的合成方法
JP2013506705A (ja) * 2009-10-06 2013-02-28 テトラエドロン ２−チオヒスチジンなどの合成方法
CN107108520A (zh) * 2014-09-22 2017-08-29 开普敦大学 合成麦角硫因及相关化合物的方法
WO2019163767A1 (ja) * 2018-02-23 2019-08-29 長瀬産業株式会社 エルゴチオネインの製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004020714A1 (de) * 2004-04-26 2005-11-10 Beiersdorf Ag Haut- und/oder Haarmittel enthaltend Verbindungen mit isoprenoider Struktur
US7767826B2 (en) 2007-10-05 2010-08-03 Pharmatech International, Inc. Process for the synthesis of L-(+)-ergothioneine
AU2013234815B2 (en) 2012-03-23 2017-06-22 The University Of Queensland Immunomodulatory agent and uses therefor
EP3252142B1 (en) * 2015-01-30 2021-11-03 Kikkoman Corporation Transformed fungus having enhanced ergothioneine productivity and method for producing ergothioneine
WO2019089878A1 (en) 2017-11-02 2019-05-09 Colorado Seminary, Owner and Operator of University of Denver Methods of treating microbial infection and inflammation
JP7185213B2 (ja) * 2018-03-02 2022-12-07 国立大学法人 筑波大学 エルゴチオネイン合成微生物、及びエルゴチオネインの製造方法

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707086A1 (fr) * 1993-06-28 1995-01-06 Bioxytech Procédé de préparation de l'ergothionéine.
CN101209229A (zh) * 2006-12-29 2008-07-02 Lvmh研究公司 L-2-硫代组氨酸或其衍生物之一作为脱色剂在化妆品中的应用
JP2009126863A (ja) * 2007-11-27 2009-06-11 Koei Kogyo Kk キノコから抽出したエルゴチオネインを高含有する組成物
CN102686568A (zh) * 2009-10-06 2012-09-19 四面体公司 麦角硫因及类似物的合成方法
JP2013506705A (ja) * 2009-10-06 2013-02-28 テトラエドロン ２−チオヒスチジンなどの合成方法
CN107108520A (zh) * 2014-09-22 2017-08-29 开普敦大学 合成麦角硫因及相关化合物的方法
WO2019163767A1 (ja) * 2018-02-23 2019-08-29 長瀬産業株式会社 エルゴチオネインの製造方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ERDELMEIER I等: "Cysteine as a Sustainable Sulfur Reagent for the Protecting‐Group‐Free Synthesis of Sulfur‐Containing Amino Acids: Biomimetic Synthesis of L‐Ergothioneine in Water", 《GREEN CHEMISTRY》, vol. 14, no. 8, 1 August 2012 (2012-08-01), pages 2256 - 2265, XP055158342, DOI: 10.1039/c2gc35367a *

Also Published As

Publication number Publication date
JPWO2021177397A1 (https=) 2021-09-10
CA3170408A1 (en) 2021-09-10
JP6864131B1 (ja) 2021-04-28
JP2021138640A (ja) 2021-09-16
EP4115881A4 (en) 2024-04-03
EP4115881A1 (en) 2023-01-11
TW202146013A (zh) 2021-12-16
BR112022017415A2 (pt) 2022-10-18
JP2026021447A (ja) 2026-02-10
WO2021177397A1 (ja) 2021-09-10
KR20220149718A (ko) 2022-11-08
US12357614B2 (en) 2025-07-15
US20230126387A1 (en) 2023-04-27

Similar Documents

Publication Publication Date Title
CN115209895A (zh) 含l-麦角硫因的组合物
US20140148504A1 (en) Novel use of flavone-based compound
JP2011032171A (ja) 美白用組成物
JP2008239619A (ja) 末梢血行改善組成物
JP2011063563A (ja) しわ改善組成物
KR102139659B1 (ko) 피부 개선용 조성물
JP4828922B2 (ja) 抗アレルギー剤
KR102124986B1 (ko) 익모초 추출물 또는 레오누린을 함유하는 근육 질환 예방 또는 치료용 또는 근 기능 개선용 조성물
TWI308152B (https=)
KR20100059375A (ko) 아스퍼질러스 테리우스 추출물, 신규 부티로락톤 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 항산화용 조성물
JP2002047193A (ja) アレルギー性皮膚炎予防または治療用組成物
EP4324336B1 (en) L-ergothioneine-containing composition
JP6456032B2 (ja) Ｓｉｒｔ１活性化剤および当該Ｓｉｒｔ１活性化剤の利用
HK40075066A (en) L-ergothioneine-containing composition
JP7727671B2 (ja) ホモシステイン誘導体及びその製造方法、組成物、並びに、炎症抑制剤
BR112022017415B1 (pt) Composição contendo l-ergotioneína
TWI918846B (zh) 升半胱胺酸衍生物及其製造方法、組成物、以及發炎抑制劑
BR122023019667B1 (pt) Método de produção de uma composição contendo l-ergotioneína e n, n-dimetil-l-2-tiohistidina e método de supressão de coloração da composição
JP7029825B2 (ja) セラミド類含有組成物の製造方法
JP7071406B2 (ja) 新規なクエルセチン系化合物を含む抗炎症組成物
US10894067B2 (en) Genome stability enhancer
JPH05213730A (ja) チロシナーゼ活性抑制剤
KR20240081842A (ko) 유색미 추출물을 유효성분으로 포함하는 피부 주름의 예방, 개선 또는 치료용 조성물
KR102138263B1 (ko) 피부 재생 또는 주름 개선용 조성물
JP2018135294A (ja) Ｎｏ産生抑制剤

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40075066

Country of ref document: HK

SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination